Cited by 937COVID-19 Impact on ReproductionSARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug Reactions

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

Open access

Shimabukuro, Tom T., Kim, Shin Y., Myers, Tanya R., Moro, Pedro L., Oduyebo, Titilope, Panagiotakopoulos, Lakshmi, Marquez, Paige L., Olson, Christine K., Liu, Ruiling, Chang, Karen T., Ellington, Sascha R., Burkel, Veronica K., Smoots, Ashley N., Green, Caitlin J., Licata, Charles, Zhang, Bicheng C., Alimchandani, Meghna, Mba-Jonas, Adamma, Martin, Stacey W., Gee, Julianne M., Meaney-Delman, Dana M.·2021·New England Journal of Medicine

DOI 10.1056/nejmoa2104983PMC PMC8117969

Open this paper in CoChat — free account

Abstract

BACKGROUND: Many pregnant persons in the United States are receiving messenger RNA (mRNA) coronavirus disease 2019 (Covid-19) vaccines, but data are limited on their safety in pregnancy. METHODS: From December 14, 2020, to February 28, 2021, we used data from the "v-safe after vaccination health checker" surveillance system, the v-safe pregnancy registry, and the Vaccine Adverse Event Reporting System (VAERS) to characterize the initial safety of mRNA Covid-19 vaccines in pregnant persons. RESULTS: A total of 35,691 v-safe participants 16 to 54 years of age identified as pregnant. Injection-site pain was reported more frequently among pregnant persons than among nonpregnant women, whereas headache, myalgia, chills, and fever were reported less frequently. Among 3958 participants enrolled in the v-safe pregnancy registry, 827 had a completed pregnancy, of which 115 (13.9%) resulted in a pregnancy loss and 712 (86.1%) resulted in a live birth (mostly among participants with vaccination in the third trimester). Adverse neonatal outcomes included preterm birth (in 9.4%) and small size for gestational age (in 3.2%); no neonatal deaths were reported. Although not directly comparable, calculated proportions of adverse pregnancy and neonatal outcomes in persons vaccinated against Covid-19 who had a completed pregnancy were similar to incidences reported in studies involving pregnant women that were conducted before the Covid-19 pandemic. Among 221 pregnancy-related adverse events reported to the VAERS, the most frequently reported event was spontaneous abortion (46 cases). CONCLUSIONS: Preliminary findings did not show obvious safety signals among pregnant persons who received mRNA Covid-19 vaccines. However, more longitudinal follow-up, including follow-up of large numbers of women vaccinated earlier in pregnancy, is necessary to inform maternal, pregnancy, and infant outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa2104983

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
Allotey, J., Fernandez, S., Bonet, M., Stallings, E., Yap, M., Kew, T., Zhou, D., Coomar, D., Sheikh, J., Lawson, H., et al. (2020) · BMJ · doi:10.1136/bmj.m3320 · Cited by 2,304
Self-citation
The Medical Dictionary for Regulatory Activities (MedDRA)
Brown, E. G., Wood, L., & Wood, S. (1999) · Drug Safety · doi:10.2165/00002018-199920020-00002 · Cited by 1,396
Evaluation and treatment of recurrent pregnancy loss: a committee opinion
(2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.048 · Cited by 1,358
Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020
Zambrano, L. D., Ellington, S., Strid, P., Galang, R. R., Oduyebo, T., Tong, V. T., Woodworth, K. R., Nahabedian, J. F., Azziz-Baumgartner, E., Gilboa, S. M., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6944e3 · Cited by 1,207
Self-citation
Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study
Gray, K. J., Bordt, E. A., Atyeo, C., Deriso, E., Akinwunmi, B., Young, N., Baez, A. M., Shook, L. L., Cvrk, D., James, K., et al. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.03.023 · Cited by 699
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Shimabukuro, T. T., Nguyen, M., Martin, D., & Destefano, F. R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 627
Self-citation
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
Oliver, S. E., Gargano, J. W., Marin, M., Wallace, M. M., Curran, K. G., Chamberland, M. E., McClung, N. M., Campos-Outcalt, D. E., Morgan, R. L., Mbaeyi, S. A., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6950e2 · Cited by 536
ACOG Practice Bulletin No. 200: Early Pregnancy Loss
(2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002899 · Cited by 503
Update on overall prevalence of major birth defects - Atlanta, Georgia, 1978-2005
(2008) · PsycEXTRA Dataset · doi:10.1037/e403792008-002 · Cited by 408
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
Oliver, S. E., Gargano, J. W., Marin, M., Wallace, M. M., Curran, K. G., Chamberland, M. E., McClung, N. M., Campos-Outcalt, D. E., Morgan, R. L., Mbaeyi, S. A., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm695152e1 · Cited by 317

Flagged first, then by citations

Show all 23 references

Research works printed but not linked: 2

Dugas C, Slane VH. Miscarriage. In: StatPearls. Treasure Island, FL: StatPearls Publishing, 2021 (https://www.ncbi.nlm.nih.gov/books/NBK532992/).
Hoyert DL, Gregory ECW. Cause-of-death data from the fetal death file, 2015-2017. Natl Vital Stat Rep 2020;69(4):1-20.32510316

Sorted by citations

Items 501–600 of 937

An immunologist's perspective on anti-COVID-19 vaccines
Milota, T., Strizova, Z. O., Smetanová, J., & Šedivá, A. (2021) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000788 · Cited by 5
The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next?
Kalampokas, T., Rapani, A., Παπαγεωργίου, Μ., Grigoriadis, S., Maziotis, E., Anifandis, G., Triantafyllidou, O., Tzanakaki, D., Neofytou, S., Bakas, P., et al. (2021) · Viruses · doi:10.3390/v13102000 · Cited by 5
Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review
Akamine, C. M., & Sahly, H. M. E. (2021) · Translational research · doi:10.1016/j.trsl.2021.12.007 · Cited by 5
COVID-19 Vaccine Hesitancy during the Perinatal Period: Understanding Psychological and Cultural Factors to Improve Care and Address Racial/Ethnic Health Inequities
Anderson, M. R., Hardy, E. J., & Battle, C. L. (2022) · Women s Health Issues · doi:10.1016/j.whi.2022.04.001 · Cited by 5
COVID-19 concerns, influenza vaccination history and pregnant women’s COVID-19 vaccine acceptance: a systematic review
Pragitara, C. F., Rahmasena, N., Ramadhani, A. T., Fauzia, S., Erfadila, R., Faraj, D. M. W., Rahmadhanti, D. C. G., & Handayani, S. (2022) · International Journal of Public Health Science (IJPHS) · doi:10.11591/ijphs.v11i2.21187 · Cited by 5
Acceptabilité du vaccin-Sars CoV-2 chez les femmes enceintes, une enquête transversale par questionnaire
Huré, M., Peyronnet, V., Sibiude, J., CAZENAVE, M. G., Anselem, O., Luton, D., Vauloup‐Fellous, C., Deruelle, P., Cordier, A., Benachi, A., et al. (2022) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2022.07.004 · Cited by 5
Vaccination Double Bind: A Study of Pregnancy and COVID-19 Vaccine Decision-Making
Campeau, K. (2022) · Rhetoric Society Quarterly · doi:10.1080/02773945.2022.2062437 · Cited by 5
COVID-19 Vaccine During Pregnancy and Perinatal Outcomes
Almutairi, A., Asiri, M., Alsuwaidan, S. D., Sufyani, R., AlSalem, S. O. K., & Alghamdi, J. S. (2023) · Cureus · doi:10.7759/cureus.33240 · Cited by 5
Obstetrical and gynecologic implications of COVID-19: what have we learned over the first two years of the pandemic
Digby, A. M., & Dahan, M. H. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06847-z · Cited by 5
Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis
Ciapponi, A., Berrueta, M. B., Ballivian, J., Bardach, A., Mazzoni, A., Anderson, S. A., Argento, F., Bok, K., Comandé, D., Goucher, E., et al. (2023) · Medicine · doi:10.1097/md.0000000000032954 · Cited by 5
Implications of COVID-19 Pandemic on Pregnancy: Current Status and Controversies
Greenberg, G. C., Vishwakarma, N., Tirupattur, M. P., Sprague, H. M., & Katwa, L. C. (2023) · COVID · doi:10.3390/covid3060062 · Cited by 5
Administration of the Coronavirus Disease 2019 (COVID-19) Vaccine to Hospitalized Postpartum Patients
Perez, M. J., Paul, R. A., Hirshberg, J. S., Aibangbee, E., Ford, T., Cooke, E., Carter, E. B., Odibo, A. O., Raghuraman, N., & Kelly, J. C. (2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004590 · Cited by 5
Myasthenia gravis and covid-19 in pregnancy: a review of the literature and case series report
Neykova, K., Миланова, М., & Ignatov, P. N. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1973418 · Cited by 5
Monitoring the safety of COVID-19 vaccination in pregnancy in the UK: A national study using the UK Obstetric Surveillance System (UKOSS), UK Teratology Information Service (UKTIS) and Vaccination in Pregnancy (VIP) safety monitoring systems
Richardson, J. L., Stephens, S., Chappell, L. C., Campbell, H. J., Amirthalingam, G., O’Boyle, S., Bukasa, A., Knight, M., & Hodson, K. K. (2022) · Obstetric Medicine · doi:10.1177/1753495x221076713 · Cited by 5
Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocol
Muñoz, F. M., Beigi, R. H., Posavad, C. M., Richardson, B. A., Chu, H. Y., Bok, K., Campbell, J. D., Cardemil, C. V., DeFranco, E., Frenck, R. W., et al. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04500-w · Cited by 6
What to Expect from COVID-19 and from COVID-19 Vaccine for Expecting or Lactating Women
Gangi, R., Corrias, A., Pintus, R., Marcialis, M. A., & Fanos, V. (2022) · Pediatric Reports · doi:10.3390/pediatric14020034 · Cited by 5
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka
Jeewandara, C., Jayampathi, K. A. C. S., Ranasinghe, T., Aberathna, I. S., Gunasekara, B., Danasekara, S., Nimasha, T., Kuruppu, H., Dissanayake, O., Gamalath, N., et al. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000607 · Cited by 5
The COVID-19 “Vaccines”: What is the truth?
Blaylock, R. L. (2022) · International Journal of Vaccine Theory Practice and Research · doi:10.56098/ijvtpr.v2i2.57 · Cited by 5
Psychological distress, vaccine, and booster acceptance in women considering or undergoing fertility treatments during the Omicron surge of the COVID-19 pandemic
Kassi, L. A., Lawson, A. K., Feinberg, E. C., Swanson, A. C., Shah, S., & Pavone, M. E. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03075-z · Cited by 5
COVID-19 Severity among Women of Reproductive Age with Symptomatic Laboratory-Confirmed SARS-CoV-2 by Pregnancy Status – United States, Jan 1, 2020 – Sep 30, 2021Preprint
Strid, P., Zapata, L. B., Tong, V. T., Zambrano, L. D., Woodworth, K. R., Riser, A. P., Galang, R. R., Gilboa, S. M., & Ellington, S. (2021) · Research Square · doi:10.21203/rs.3.rs-1090075/v1 · Cited by 5
Self-citation
Protective vaccinations during pregnancy - adult Poles knowledge in this area
Dąbek, J., Sierka, O., Kulik, H., & Gąsior, Z. (2021) · BMC Public Health · doi:10.1186/s12889-021-11336-0 · Cited by 4
Factors influencing uptake of the COVID ‐19 vaccination among pregnant women in Australia: A cross‐sectional survey
Javid, N., Phipps, H., Homer, C., de Vries, B. S., Kaufman, J., Danchin, M. H., & Hyett, J. A. (2023) · Birth · doi:10.1111/birt.12741 · Cited by 4
A qualitative study of pregnant women’s perceptions and decision-making regarding COVID-19 vaccination in Thailand
Chawanpaiboon, S., Anuwutnavin, S., Kanjanapongporn, A., Pooliam, J., & Titapant, V. (2024) · Scientific Reports · doi:10.1038/s41598-024-55867-z · Cited by 4
The burden, pathogenesis, clinical outcomes, and treatment of common respiratory virus infections during pregnancy
Rumfelt, K. E., Englund, J. A., & Kachikis, A. B. (2025) · Women s Health · doi:10.1177/17455057251338501 · Cited by 4
Maternal vaccination to prevent neonatal infections and combat antimicrobial resistance
Galiza, E. P., Nakebembe, E., Mboizi, R. B., Okek, E. J., & Doaré, K. L. (2025) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2025.101680 · Cited by 4
Restoring trust in vaccination: listening to patients and acknowledging Post-Acute COVID Vaccine Syndrome
Halma, M. T. J., & Varón, J. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1688170 · Cited by 4
Schwangere Mitarbeiterinnen im Gesundheitswesen: Schutz durch Impfen gegen SARS-CoV-2 und Tragen von FFP2-Masken
Ochmann, U., Wicker, S., & Michels, G. (2021) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-021-00832-1 · Cited by 5
Anti‐human leukocyte antigen and anti‐ABO antibodies after SARS‐CoV‐2 mRNA vaccination in kidney transplant recipients
Nishida, H., Takai, S., Ito, H., Fukuhara, H., Nawano, T., Narisawa, T., Kanno, H., Yagi, M., Yamagishi, A., Sakurai, T., et al. (2023) · Clinical Transplantation · doi:10.1111/ctr.14952 · Cited by 4
Strategies to Address COVID-19 Vaccine and Pregnancy Myths
Berkowitz, H. E., & Vann, J. C. J. (2023) · MCN The American Journal of Maternal/Child Nursing · doi:10.1097/nmc.0000000000000926 · Cited by 4
IgG antibody levels against the SARS-CoV-2 spike protein in mother–child dyads after COVID-19 vaccination
Muñoz‐Gómez, M. J., Martin‐Vicente, M., Vigil‐Vázquez, S., Carrasco, I., Hernanz‐Lobo, A., Más, V., Vázquez, M., Manzanares, Á., Cano, O., Zamora, C., et al. (2023) · Infection · doi:10.1007/s15010-023-02111-x · Cited by 5
The fast-track development of COVID-19 vaccines
El‐Maradny, Y. A., Ramadan, A. A., Chavda, V. P., Balar, P. C., & Redwan, E. M. M. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18564-9.00027-8 · Cited by 5
Efficacy and Clinical Outcomes of mRNA COVID-19 Vaccine in Pregnancy: A Systematic Review and Meta-Analysis
Santimano, A. J., Al‐Zoubi, R. M., Al-Qudimat, A. R., Darwish, M. B. A., Ojha, L. K., Rejeb, M. A., Hamad, Y., Elrashid, M. A., Ruxshan, N. M., Omri, A. E., et al. (2024) · Intervirology · doi:10.1159/000538135 · Cited by 4
Expecto Patronum! Leveraging the Positive Force of COVID-19 Vaccines for Pregnant and Lactating Individuals
Malinowski, A. K., Whittle, W. L., Murphy, K. E., & Kingdom, J. C. (2021) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2021.04.015 · Cited by 4
Healthcare Considerations for Special Populations during the COVID-19 Pandemic: A Review
Kim, J., Im, Y., Song, J., & Jang, S. J. (2021) · Journal of Korean Academy of Nursing · doi:10.4040/jkan.21156 · Cited by 4
Maternal vaccination: A narrative review
Ashkir, S., Khaliq, O. P., Hunter, M. B., & Moodley, J. (2022) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v37i1.451 · Cited by 4
Maternal influenza vaccination preferentially boosts hemagglutinin stem‐specific antibody resulting in efficient transplacental transfer of stem‐specific IgG
Zuber, M. J., Stamilio, D. M., Holbrook, B. C., Snively, B. M., Jensen, E. T., & Alexander‐Miller, M. A. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14686 · Cited by 5
A Statistical Synopsis of COVID-19 Components and Descriptive Analysis of Their Socio-Economic and Healthcare Aspects in Bangladesh Perspective
Uddin, M., Shawpnil, K., Mugdha, S. B. S., & Ahmed, A. (2023) · Journal of Environmental and Public Health · doi:10.1155/2023/9738094 · Cited by 4
Rates of Spontaneous Abortion in Israel Before and During the COVID-19 Pandemic
Travis-Lumer, Y., Goldberg, Y., Kodesh, A., Reichenberg, A., Sandin, S., Frangou, S., & Levine, S. Z. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.0233 · Cited by 4
Reduction in preterm birth among COVID-19–vaccinated pregnant individuals in the United States
Darwin, K. C., Kohn, J. R., Shippey, E., Uribe, K. A., Gaur, P., & Eke, A. C. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.101114 · Cited by 4
Effects of Biological Sex and Pregnancy on SARS-CoV-2 Pathogenesis and Vaccine Outcomes
Shapiro, J. R., Roberts, C. W., Arcovio, K., Reade, L., Klein, S. L., & Dhakal, S. (2023) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-35139-6_4 · Cited by 4
Effectiveness of the Original COVID-19 Vaccine against COVID-19 Exacerbations during the Omicron Wave: A Population-based Study in Okayama, Japan
Matsumoto, N., Mitsuhashi, T., Matsuo, R., Kadowaki, T., Takao, S., & Yorifuji, T. (2023) · JMA Journal · doi:10.31662/jmaj.2023-0019 · Cited by 4
Impact of coronavirus disease 2019 vaccination on live birth rates after in vitro fertilization
Applebaum, J. C., Humphries, L. A., Kravitz, E., Taberski, S., Koelper, N., Gracia, C. R., & Berger, D. S. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.11.033 · Cited by 4
Evaluating COVID-19 vaccine effectiveness during pre-Delta, Delta and Omicron dominant periods among pregnant people in the USA: Retrospective cohort analysis from a nationally sampled cohort in National COVID Collaborative Cohort (N3C)
Qin, Q., Wilkins, K. J., Jones, S. E., Bradwell, K. R., Chan, L., Sun, J., Anzalone, J., Zheng, Q., Liebman, M., Mariona, F., et al. (2024) · BMJ Public Health · doi:10.1136/bmjph-2023-000770 · Cited by 4
Should women undergoing in vitro fertilization treatment or who are in the first trimester of pregnancy be vaccinated immediately against COVID-19
Snook, M. L., Beigi, R. H., Legro, R. S., & Paules, C. I. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.05.083 · Cited by 4
Vaccination against COVID-19 infection: the need of evidence for diabetic and obese pregnant women
Lapolla, A., Dalfrà, M. G., & Burlina, S. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01764-0 · Cited by 4
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease
Benchimol, E. I., Carroll, M. W., Geist, R., Griffiths, A. M., Huang, J. G., Mack, D. R., Bernstein, C. N., Bitton, A., Jones, J., Kaplan, G. G., et al. (2021) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwab030 · Cited by 4
Current status of COVID-19 vaccination: safety and liability concern for children, pregnant and lactating women
Das, S. K., Paul, M., Behera, B. C., & Thatoi, H. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2056025 · Cited by 4
Attitudes of family medicine residents in Ankara towards COVID-19 vaccines administered in Turkey: a descriptive, cross-sectional study
Çevik, H. S., Baykan, R., Peker, A., & Tekner, S. (2022) · Family Medicine & Primary Care Review · doi:10.5114/fmpcr.2022.115871 · Cited by 4
An update on teratogens for pediatric healthcare providers
Valladares, D. A., & Rasmussen, S. A. (2022) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001177 · Cited by 4
Written Briefing and Oral Counseling Increase the Willingness to Receive the SARS-CoV-2 Vaccination among Women in Puerperium: A Qualitative Prospective Cohort Study
Schirwani, N., Pateisky, P., Koren, T., Farr, A., Kiss, H., & Bancher‐Todesca, D. (2022) · Vaccines · doi:10.3390/vaccines10091505 · Cited by 4
Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199
Stroobandt, S., & Stroobandt, R. (2021) · Viruses · doi:10.3390/v13081545 · Cited by 4
Adjustment is required to calculate the risk of early pregnancy loss with COVID-19 infection or vaccination
Sun, H. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.08.002 · Cited by 4
Embarazo y vacunación COVID-19
Garcia, A. T. (2021) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2021.100718 · Cited by 4
Safety profile of COVID-19 vaccines in pregnant and postpartum women in brazilPreprint
Qiao, Y., de Abreu, A. D. J. L., Dias, C. Z., Meng, X., Ferreira, R. V., Pereira, R. G., Julian, G. S., & Yin, W. (2021) · medRxiv · doi:10.1101/2021.12.14.21267777 · Cited by 4
Pregnancy and the SARS-CoV-2 pandemic
Reynolds, R. M., Stock, S. J., Denison, F. C., Maybin, J. A., & Critchley, H. (2022) · Physiological Reviews · doi:10.1152/physrev.00003.2022 · Cited by 4
Developing Strategies for Weathering the Storms of a Global Pandemic at Preschool and Sentiments Analysis of Behavior Toward Public Health MeasuresPreprint
Cardona, T. L. C., Akpan, I. J., Schlosser, N., & Hennis, B. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4134481 · Cited by 4
Viral Infections of the Fetus and Newborn
Stokes, C., & Melvin, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82823-9.00034-9 · Cited by 4
Differentiating COVID-19 vaccine-related adverse events from long COVID: A comprehensive review of clinical manifestations, pathophysiology, and diagnostic approaches
Domingo, J. L. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127842 · Cited by 3
COVID-19 vaccination status during pregnancy and preeclampsia risk: the pandemic-era cohort of the INTERCOVID consortium
Cavoretto, P. I., Villar, J., Farina, A., Fabre, M., Deruelle, P., Agudelo, A. C., Ayede, A. I., Ernawati, E., Conti, C. P. S., Bako, B., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.103785 · Cited by 3
Assessing the Impact of Hepatitis B Elimination Program on Maternal-Infant Health in West Java, Indonesia: A Cross-Sectional Study
Anwar, A. D., Nugrahani, A. D., Santoso, D. P. J., Aziz, M. A., Ulfah, L., & Surachman, A. (2023) · Medical Science Monitor · doi:10.12659/msm.941639 · Cited by 3
COVACPREG, a French prospective cohort study of women vaccinated against COVID-19 during pregnancy
Lacroix, I., Caillet, A., Delteil, L., Ameur, H., Padelli, N., Hurault‐Delarue, C., & Cottin, J. (2024) · Therapies · doi:10.1016/j.therap.2024.06.003 · Cited by 3
Comparing the immunogenicity of COVID-19 infection and vaccination in pregnant women as measured by anti-S IgG
hemati, Z., Ameli, S., Nikkhoo, B., Shahgheibi, S., Seyedoshohadaei, F., Soufizadeh, N., & Rahmani, K. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09853-5 · Cited by 3
Disparities in COVID-19 Vaccine Uptake Among Pregnant People in a Diverse Urban Population With High Vaccine Acceptance
Blauvelt, C. A., Pullins, M. J., & Gaw, S. L. (2024) · AJPM Focus · doi:10.1016/j.focus.2024.100303 · Cited by 3
Safety, Efficacy, and Effectiveness of Maternal Vaccination against Respiratory Infections in Young Infants
Makan, N., Madhi, S. A., & Dangor, Z. (2024) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2471-6906 · Cited by 3
Infections pendant la grossesse : progrès thérapeutiques
Mandelbrot, L. (2021) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2021.12.001 · Cited by 3
Vaccine Hesitancy, Vaccine Acceptance, and Recommendations about the COVID-19 Vaccines
Alexander, C. A., Wang, L., & Shah, V. (2021) · Research Review · doi:10.52845/jmrhs/2021-4-12-2 · Cited by 3
COVID-19 in perinatal period: questions and consequences
Tunçel, D., Bilgin, L., İnce, Z., & Çoban, A. Ç. (2022) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2021.890 · Cited by 3
Prenatal Immunization to Prevent Viral Disease Outcomes During Pregnancy and Early Life
Goswami, R., Pavon, C. G., Miller, I. G., Berendam, S. J., Williams, C. A., Rosenthal, D., Gross, M., Phan, C. T., Byrd, A., Pollara, J., et al. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.849995 · Cited by 3
Assessment of Anti m-RNA SARS-CoV-2 (BNT162b2) Antibody Titres in Mother and Child Pairs of Breastfeeding Women Vaccinated Post-Delivery
Kociszewska‐Najman, B., Jaskólska, M., Taradaj, K., Sibanda, E., & Ginda, T. (2022) · Vaccines · doi:10.3390/vaccines10071089 · Cited by 3
Estimating the Effectiveness of Shielding during Pregnancy against SARS-CoV-2 in New York City during the First Year of the COVID-19 Pandemic
Chen, S., Murphy, E. A., Pendergrass, A. G., Sukhu, A. C., Eng, D., Jurkiewicz, M., Mohammed, I. A., Rand, S., White, L. J., Hupert, N., et al. (2022) · Viruses · doi:10.3390/v14112408 · Cited by 3
Behavioral and Cultural Insights, a Nationwide Study Based on Repetitive Surveys of WHO Behavioral Insights Tool in Greece Regarding COVID-19 Pandemic and Vaccine Acceptance
Prezerakos, P. E., Dadouli, K., Agapidaki, E., Kravvari, C.-M., Avakian, I., Peristeri, A.-M., Anagnostopoulos, L., Mouchtouri, V. Α., Fountoulakis, K. Ν., Koupidis, S. A., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010216 · Cited by 3
A Review of Coronavirus Disease 2019 in Pregnancy
Zamparini, J. M., Saggers, R. T., & Buga, E. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1758853 · Cited by 3
Inflammatory and Immune Responses during SARS-CoV-2 Infection in Vaccinated and Non-Vaccinated Pregnant Women and Their Newborns
Zelini, P., d’Angelo, P., Zavaglio, F., Soleymaninejadian, E., Mariani, L., Perotti, F., Dominoni, M., Tonello, S., Sainaghi, P. P., Minisini, R., et al. (2023) · Pathogens · doi:10.3390/pathogens12050664 · Cited by 4
Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccines among pregnant women (the EPIC study): study protocol
Andraweera, P. H., Wang, B., Danchin, M. H., Blyth, C. C., Vlaev, I., Ong, J. J., Dodd, J. M., Couper, J., Sullivan, T., Karnon, J. D., et al. (2023) · Trials · doi:10.1186/s13063-023-07485-9 · Cited by 3
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons
Zerbo, O., Ray, G. T., FIREMAN, B. H., Layefsky, E., Goddard, K., Ross, P., Greenberg, M., & Klein, N. P. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2256042 · Cited by 3
Establishing vaccine pregnancy registries and active surveillance studies in low-and middle-income countries: Experience from an observational cohort surveillance project in The Gambia
Kochhar, S., Okomo, U. A., Nkereuwem, O., Shaum, A., Gidudu, J., Bittaye, M., Fofana, S., Marena, M., Kaira, M. J., Kampmann, B., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.09.038 · Cited by 3
Maternal antibody transfer rate of vaccination against SARS‐CoV‐2 before or during early pregnancy and its protective effectiveness on offspring
Liu, S., Wang, P., Shi, X., Weng, T., Zhong, J., Zhang, X., Qu, J. T., Chen, L., Xu, Q., Meng, X., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29125 · Cited by 3
Immune response and safety of inactivated SARS-CoV-2 vaccines during pregnancy: a real-world observational study
Gong, Y., Zhang, X., Han, X., Chen, B., Xu, Y., Huang, J., Yang, W., Fu, X., Wang, Q., Li, Z., et al. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2272655 · Cited by 3
Knowledge, attitudes, and practices towards COVID-19 and COVID-19 vaccines among Obstetrician-Gynaecologists
Bragazzi, N. L., Buchinger, M., Szarpak, Ł., Chmielewski, J. P., Goździewska, M., Gotlib, J., & Khamisy‐Farah, R. (2023) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/176959 · Cited by 3
Discovery and development of COVID-19 vaccines and therapeutics: nonclinical perspectives
Khan, N. A., Sathish, J. G., & Rohde, C. M. (2024) · The Journal of Toxicological Sciences · doi:10.2131/jts.49.79 · Cited by 3
Exploring COVID-19 vaccine adverse events among pregnant women: a cross-sectional study, 2022
Amer, A. A., Amer, S. A., Badokhon, A., Hammad, S. M., Wasfy, M. A., Khan, M., Al-Harbi, T. A., Alobaid, S. Q., Eskander, G., Abdel-Azeem, A. M., et al. (2024) · Therapeutic Advances in Vaccines and Immunotherapy · doi:10.1177/25151355241285594 · Cited by 3
COVID-19, embarazo, vacunas y lactancia materna
Mora, E. L., Espinoza, J., Dabanch, J., & Cruz, R. (2021) · Boletín micológico · doi:10.22370/bolmicol.2021.36.1.2854 · Cited by 3
Listening to Twitter about Adverse Events of the Comirnaty COVID-19 Vaccine during first weeks of immunisation in Poland
Jarynowski, A. K., Kaczmar, K., & Madej, M. (2021) · E-methodology · doi:10.15503/emet2020.85.92 · Cited by 3
Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on “Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199”
Stückelberger, S., Favre, G., Ceulemans, M., Gerbier, E., Lambelet, V., Stojanov, M., Winterfeld, U., Baud, D., Panchaud, A., & Pomar, L. (2021) · Viruses · doi:10.3390/v13081546 · Cited by 3
Safety and efficiency of COVID-19 vaccination during pregnancy and breastfeeding
Błaszczyk, E. (2022) · Ginekologia Polska · doi:10.5603/gp.a2021.0241 · Cited by 3
COVID-19 and the Unraveling of Experimental Medicine - Part II
Thorp, K. E., & Thorp, J. A. (2022) · The Gazette of Medical Sciences · doi:10.46766/thegms.pubheal.22022804 · Cited by 3
COVID-19 Vaccine Acceptance and Hesitancy among Health Care Workers (HCWs) In Two Major Urban Centers in Khyber-Pakhtunkhwa, Pakistan
Khan, S., Uddin, A., Imran, M., Ali, Y., Khan, S. U., Khan, M. S., Trutter, B., Asfandiyar, M., & Iqbal, Z. (2022) · Asia Pacific Journal of Public Health · doi:10.1177/10105395221083382 · Cited by 3
COVID-19 vaccination in pregnancy: Experience in Viet Nam
Vuong, L. N., Chau, M., Nguyen, D. L., Pham, T. D., Mol, B. W., & Ho, T. M. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.05.008 · Cited by 3
Responses to comments on my paper: “COVID Update: What is the truth?”
Blaylock, R. L. (2022) · Surgical Neurology International · doi:10.25259/sni_578_2022 · Cited by 3
Cross-Sectional Survey of Views on COVID-19 and Its Vaccines Among Pregnant Women
Li, Y. Y., Lok, W., Poon, L. C., Kong, C. W., & To, W. W. K. (2022) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000149 · Cited by 3
Maternal COVID-19 Vaccine May Reduce the Risk of MIS-C in Infants: A Narrative Review
Mangat, C., Yarrarapu, S. N. S., Singh, G., & Bansal, P. (2022) · Vaccines · doi:10.3390/vaccines10091454 · Cited by 3
Knowledge and attitudes of pregnant women about Coronavirus vaccines in Turkiye
Odabaş, R. K., Demir, R., & TAŞPINAR, A. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2144174 · Cited by 3
Preliminary results of COVID ‐19 vaccination among Taiwanese pregnant women: A single‐center, prospective, case–control study
Law, K.-S., Hsu, Y., & Chen, H. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14682 · Cited by 3
Effects of gender on the efficacy and response to COVID-19 vaccination; a review study on current knowledge
Rastegar-Kashkouli, A., Jafari, M., & Yousefi, P. (2022) · Journal of Renal Endocrinology · doi:10.34172/jre.2022.25064 · Cited by 3
Reducing COVID-19 Vaccine Hesitancy From a Decisional Conflict Model: A Cross-Sectional Study
Hiroyama, N., Okubo, N., Takahashi, N., & Misumi, J. (2023) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580231162524 · Cited by 3
Acute reactions after a homologous primary COVID-19 vaccination series: Analysis of Taiwan V-Watch data
Su, W., Chan, K. A., Chuang, J.-H., Wang, T.-A., Chen, S.-F., Chang, Y.-C., Chen, M., Chang, C.-C., & Yang, C.-H. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.03.042 · Cited by 3
Strategies to reduce COVID‐19 vaccine hesitancy among pregnant individuals: Data from a prospective survey of unvaccinated pregnant women
Binger, K. S., Cui, Y., Kelly, J. A., & Palatnik, A. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14799 · Cited by 3
Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon
Powell, J., & Piszczatoski, C. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280211058387 · Cited by 3
Deferring Risk: Limitations to the Evidence in Product Labels for Vaccine Use in Pregnancy
Manca, T., Top, K. A., Weagle, K., & Graham, J. (2022) · Journal of Women s Health · doi:10.1089/jwh.2021.0609 · Cited by 3
COVID-19 & Disaster Capitalism – Part I
Thorp, K. E., Thorp, M. M., Thorp, E. M., Thorp, E. M., BS, F. W., & Thorp, J. A. (2022) · The Gazette of Medical Sciences · doi:10.46766/thegms.medethics.22071901 · Cited by 3

Authors: Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., Marquez, P. L., Olson, C. K., Liu, R., Chang, K. T., Ellington, S. R., Burkel, V. K., Smoots, A. N., Green, C. J., Licata, C., Zhang, B. C., Alimchandani, M., Mba-Jonas, A., Martin, S. W., Gee, J. M., & Meaney-Delman, D. M.
Affiliations: National Center on Birth Defects and Developmental Disabilities (US)
From the Immunization Safety Office, Division of Healthcare Quality Promotion (T.T.S., T.R.M., P.L. Moro, L.P., P.L. Marquez, C.K.O., C.L., B.C.Z., J.M.G.), and the Arboviral Diseases Branch, Division of Vector-Borne Diseases (S.W.M.), National Center for Emerging and Zoonotic Infectious Diseases, the Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities (S.Y.K., V.K.B., C.J.G., D.M.M.-D.), the Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion (T.O., K.T.C., S.R.E., A.N.S.), the World Trade Center Health Program, National Institute for Occupational Safety and Health (R.L.), and the Epidemic Intelligence Service (K.T.C.) — all at the Centers for Disease Control and Prevention, Atlanta; and the Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (M.A., A.M.-J.).
Corresponding author: Shimabukuro, Tom T.
ORCID: Shimabukuro, Tom T.
Kim, Shin Y.
Myers, Tanya R.
Moro, Pedro L.
Panagiotakopoulos, Lakshmi
Olson, Christine K.
Liu, Ruiling
Chang, Karen T.
Ellington, Sascha R.
Burkel, Veronica K.
Green, Caitlin J.
Alimchandani, Meghna
Martin, Stacey W.
Gee, Julianne M.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2021-06-17
Volume: 384
Issue: 24
Pages: 2273-2282
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa2104983
PMC: PMC8117969
OpenAlex: W3154888372
Cited by: 927
References: 23
Citations by year: 2026: 37 · 2025: 46 · 2024: 84 · 2023: 194 · 2022: 317 · 2021: 246
FWCI: 190.97
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: New England Journal of Medicine (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Centers for Disease Control and Prevention
Topics: Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords: COVID-19 mRNA vaccine, vaccine safety in pregnancy, pregnant women, injection site pain, miscarriage, preterm birth, small for gestational age, neonatal outcomes, live birth, adverse pregnancy outcomes, VAERS
MeSH terms: Abortion, Spontaneous, COVID-19 Vaccines, mRNA Vaccines, Adolescent, Adult, Female, Humans, Infant, Newborn, Infant, Small for Gestational Age, Middle Aged, Pregnancy, Registries, United States, Vaccines, Synthetic, Adverse Drug Reaction Reporting Systems, Premature Birth, Young Adult, Public Health Surveillance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks